Virtual Neuro-Navigation System for Personalized Community-Based TMS
Sponsor: |
Soterix Medical Inc. and National Institute of Mental Health |
Enrolling: |
Male and Female Patients |
Study Length: |
2 Months |
IRB Number: |
AAAU2047 |
U.S. Govt. ID: |
NCT04956081 |
Contact: |
Rashel Mejia: / rashel.mejia@nyspi.columbia.edu |
Are you suffering from chronic depression? We are seeking participants for a depression treatment research study at Columbia University using Transcranial Magnetic Stimulation (TMS). This study develops a more accurate TMS to treat chronic depression. Participation includes clinical assessments and magnetic resonance imaging (MRI). You will receive 27 sessions of TMS treatment over up to 8 weeks. This study will test a novel form of neuronavigated transcranial magnetic stimulation (rTMS) which may achieve better results than conventional rTMS by using a specially processed MRI image to optimize targeting of brain regions thought to contribute to depression. Patients with treatment-resistant depression including those for whom conventional rTMS was not successful may be eligible to participate.
This study is closed
Investigator
Joshua Berman, MD, PhD
Are you diagnosed with Major Depressive Disorder (MDD)? |
Yes |
No |
Do you live in NYC / Can you comfortably travel to NYC for the duration of the study? |
Yes |
No |
Are you currently pregnant or breastfeeding? |
Yes |
No |
Can you commit to daily TMS treatment, 5-days a week? |
Yes |
No |